Cargando…

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits

INTRODUCTION: The purpose of this study was to examine and compare the conjunctival irritation (congestion, swelling, and discharge) of topical bimatoprost ophthalmic solution 0.01% and bimatoprost ophthalmic solution 0.03% in rabbits. METHODS: Six healthy New Zealand White rabbits were treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogundele, Abayomi B, Li, Guangming, Ellis, Joel J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827189/
https://www.ncbi.nlm.nih.gov/pubmed/20186281
_version_ 1782177923145400320
author Ogundele, Abayomi B
Li, Guangming
Ellis, Joel J
author_facet Ogundele, Abayomi B
Li, Guangming
Ellis, Joel J
author_sort Ogundele, Abayomi B
collection PubMed
description INTRODUCTION: The purpose of this study was to examine and compare the conjunctival irritation (congestion, swelling, and discharge) of topical bimatoprost ophthalmic solution 0.01% and bimatoprost ophthalmic solution 0.03% in rabbits. METHODS: Six healthy New Zealand White rabbits were treated with either bimatoprost 0.01% or bimatoprost 0.03% (3 animals/group). One dose (2 drops/dose) of study medication was administered to the right eye of each animal every 30 minutes for 4.5 hours. Approximately 1 hour after the last dose, conjunctival irritation was assessed using a slit-lamp biomicroscope to individually evaluate conjunctival congestion, swelling, and discharge. RESULTS: The mean conjunctival congestion, swelling and discharge scores for bimatoprost 0.03% were 1.67, 0.33 and 0.33, respectively, and for bimatoprost 0.01% were 2.00, 0.33 and 1.33, respectively. CONCLUSIONS: Despite the lower drug concentration of the 0.01% formulation, bimatoprost 0.01% does not reduce conjunctival irritation, including conjunctival congestion, swelling, and discharge, in rabbits compared to bimatoprost 0.03%. Further studies would be needed to determine whether the increase in the mean conjunctival congestion and discharge scores may be attributed to the increased BAK concentration in the bimatoprost 0.01% formulation.
format Text
id pubmed-2827189
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-28271892010-02-25 Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits Ogundele, Abayomi B Li, Guangming Ellis, Joel J Clin Ophthalmol Original Research INTRODUCTION: The purpose of this study was to examine and compare the conjunctival irritation (congestion, swelling, and discharge) of topical bimatoprost ophthalmic solution 0.01% and bimatoprost ophthalmic solution 0.03% in rabbits. METHODS: Six healthy New Zealand White rabbits were treated with either bimatoprost 0.01% or bimatoprost 0.03% (3 animals/group). One dose (2 drops/dose) of study medication was administered to the right eye of each animal every 30 minutes for 4.5 hours. Approximately 1 hour after the last dose, conjunctival irritation was assessed using a slit-lamp biomicroscope to individually evaluate conjunctival congestion, swelling, and discharge. RESULTS: The mean conjunctival congestion, swelling and discharge scores for bimatoprost 0.03% were 1.67, 0.33 and 0.33, respectively, and for bimatoprost 0.01% were 2.00, 0.33 and 1.33, respectively. CONCLUSIONS: Despite the lower drug concentration of the 0.01% formulation, bimatoprost 0.01% does not reduce conjunctival irritation, including conjunctival congestion, swelling, and discharge, in rabbits compared to bimatoprost 0.03%. Further studies would be needed to determine whether the increase in the mean conjunctival congestion and discharge scores may be attributed to the increased BAK concentration in the bimatoprost 0.01% formulation. Dove Medical Press 2010 2010-02-18 /pmc/articles/PMC2827189/ /pubmed/20186281 Text en © 2010 Ogundele et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Ogundele, Abayomi B
Li, Guangming
Ellis, Joel J
Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
title Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
title_full Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
title_fullStr Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
title_full_unstemmed Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
title_short Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
title_sort impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827189/
https://www.ncbi.nlm.nih.gov/pubmed/20186281
work_keys_str_mv AT ogundeleabayomib impactoftopicalbimatoprost001andbimatoprost003onconjunctivalirritationinrabbits
AT liguangming impactoftopicalbimatoprost001andbimatoprost003onconjunctivalirritationinrabbits
AT ellisjoelj impactoftopicalbimatoprost001andbimatoprost003onconjunctivalirritationinrabbits